Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Otitis Externa”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 37 records · Page 2Linked to original sources
PubMed2002

Allergic otitis externa.

Chronic otitis externa is a common condition, which is usually successfully treated by topical medications and aural toilet. In cases that persist despite conventional treatment, a diagnosis of allergic otitis externa should be considered. Sensitization to otic medications (secondary contact otitis) is not uncommon. Topical aminoglycosides are the most common sensitizers although many components of topical preparations can cause sensitization. Patients who may have developed allergic otitis externa should undergo patch testing. Otolaryngologists should consider using topical antibiotics with a low allergenic potential and avoiding neomycin when treating patients with otitis externa. Primary contact otitis may occur to metals used in earrings and also to hearing aid moulds. Treatment of both primary and secondary contact otitis consists of identifying the allergen, avoiding further contact and use of simple preparations avoiding common sensitizers.

Chronic Disease↗
PubMed2000

[Bacteriologic evaluation of otitis externa and chronic otitis media].

The authors present results of bacteriological examinations in 187 patients with chronic otitis media (OMC) and otitis externa treated in ENT Department, Medical University of Gdańsk in the years 1997-1998. Ear swabs and aspirates were investigated for aerobes and anaerobes 254 bacterial isolates were obtained. Among 150 patients with OMC aerobes were isolated in 130 (86.7%) in 13 (8.5%) mixed aero-anaerobes flore and in 20 (19.3%) no bacterial growth was observed. From patients with COM there were 199 bacterial isolates among them 177 aerobes cultures, 13 anaerobes and 9 fungal. From the external ear canal there were 55 cultures, among them 45 (81.8%) aerobes, 6 (10.9%) mixed aero-anerobes and 4 (7.3%) fungal. The most frequent observed bacteria were Staphylococcus aureus, Pseudomonas aeruginosa and Proteus mirabilis which showed the best susceptibility on ciprofloxacine and amikacine.

Adolescent↗
PubMed1993

What causes acute otitis externa?

External otitis is an extremely common condition and can affect between five to twenty per cent of the patients attending ENT clinics (Hawke et al., 1984). Its precise pathogenesis remains unclear, despite several aetiological classifications in the literature. The aim of this study was to investigate the relationship between infection, water exposure and trauma and the development of acute otitis externa. The study comprised 100 patients with their first attack of otitis externa and 150 age and sex matched controls. In only 40 per cent of cases could a primary microbiological cause be found. There was no significant statistical difference found between the two groups regarding the use of agents capable of traumatizing the external canal. Regular swimming, showering and hair washing were significantly more common in patients with acute otitis externa. Allergic disorders were nearly three times more common in the external otitis group suggesting a possible immunological aetiology.

Acute Disease↗
PubMed1999

Practical guide to otitis externa.

BACKGROUND: Otitis externa is a common condition in warm humid climates, hence the term tropical ear. It is more likely to occur in a population were swimming is a popular pastime. OBJECTIVE: This article discusses otitis externa in terms of the clinicopathological categorisation. Its aim is to provide practical advice for the diagnosis, office management and prevention of this condition. DISCUSSION: The key elements to successful treatment of otitis externa are appropriate microbiological diagnosis and meticulous management.

Australia↗
PubMedDate not supplied

Otitis externa sicca/fibrotising external otitis (FEO) as a complication of Sjögren's syndrome.

Sjögren's syndrome (SS) is a condition characterized by sicca symptoms and by autoimmune features. We describe two SS patients with otitis externa fibroticans/sicca. One of these 2 patients developed a lesion of the tympanic membrane making it necessary to perform a tympantomy and meatoplasty. Our findings suggest firstly that the epithelial cell-mediated secretion of lamellar bodies and the production of the permeability barrier are defective in SS. Secondly, local moisturing and/or topical corticosteroid treatment in SS patients with sicca symptoms in the auditory canal could help to avoid reconstructive surgical treatment.

Deafness↗
PubMedDate not supplied

Acute otitis externa.

Acute otitis externa is a common presenting disorder seen in many primary care offices. Serious complications may be avoided by appropriate diagnosis and treatment. This article will summarize the basic anatomy and physiology of the external auditory canal, the pathophysiology and microbiology of acute otitis externa, the clinical presentation and diagnosis of this disease, and its potential complications and treatment.

Acute Disease↗
PubMed1989

Diagnosis, complications, and treatment of malignant otitis externa.

Malignant otitis externa (MOE) is a severe penetrating infection which has spread outside the confines of the external auditory canal to involve temporal bone, mastoid air cells and periaural soft tissues. It is a rare but important condition, having a mortality rate of between 23%-75%. Clinical diagnosis in the early stage is difficult because the symptoms are similar to acute otitis externa. Diabetes Mellitus is an important predisposing factor present in up to 94% of patients. Two cases of MOE are presented underlining the clinical findings, spectrum of activity and treatment of the disease, and stressing the importance of early diagnosis.

Adult↗
PubMed1989

[Personal studies on the current spectrum of pathogenic bacteria in otitis externa and chronic otitis media].

From 1985-1987 smears (for Gram staining) and swabs (for culture and antibiogram) were done in 294 patients suffering from chronic otitis media, and in 67 cases of external otitis. Besides the comparison of these two procedures, the microbial spectrum in case of external otitis and chronic otitis media is considered and compared to the literature. Pseudomonas aeruginosa and Staphylococcus aureus are the most frequent pathogens. Often gram-positive rod-shaped bacilli were also found, the pathogenicity of which has been underestimated in the literature up to now. The anaerobes did not play an important role in our patients. The value of gram staining (immediate information and safer antibiotic therapy) is pointed out on the basis of the reported results.

Bacteria↗
PubMed1995

An alternative to regular dressings for otitis externa and chronic supperative otitis media?

Otitis externa and chronic otitis media often present to the otolaryngologist with a discharging ear. The conventional method of treatment is to perform regular aural toilet and insert medicated dressings into the external auditory canal. This treatment is either performed by trained nurses or medical staff, but in either case is time consuming. This study compares the efficacy of the above standard regimen with a novel treatment where a single aural toilet is carried out and medicated ointment instilled into the ear. Both regimens were evaluated at three weeks. Our results shows that there was no significant difference between the two treatment regimens with regard to the resolution of either of the conditions studied or the improvement in the symptom status of the patients. On the basis of this it would seem that a single aural toilet and instillation of medicated ointment is a valid treatment option, cuts down hospital attendance and could be performed in the community by general medical practitioners or trained practice nurses.

Administration, Topical↗
PubMed1996

Malignant otitis externa.

Malignant otitis externa is an uncommon but serious infection involving the external auditory canal, temporal bone, and surrounding soft tissue. Most commonly this infectious process is seen in elderly diabetics. In this article the pathogenesis, clinical features, diagnosis, and therapy are reviewed.

Humans↗
PubMed1983

[The pathogenesis of otitis externa].

In otitis externa the formerly grampositive colonization of the auditory canal changes towards a gramnegative microbial flora. Pseudomonas aeruginosa plays a major role in recurrent infections and in swimmer's ears. Various serotypes of ps. aeruginosa i.e. type 1;6 and 5 could be isolated. In swimmer's ears ps. maltophilia was identified twice. There was no correlation between the severity of the disease and the protease and lipase activity of pseudomonas isolates. Exoenzyme activity seemed to bear influence on the chronicity of the disease. Therapeutic success led to a decline of enzymatic activity.

Adult↗
PubMed1983

[Malignant otitis externa].

Malignant otitis externa represents a special form of inflammatory alteration of the external ear. The inflammation can spread to surrounding bones (temporal bone, skull base - to the foramen magnum), as well as to neighbouring tissue, such as the parotid gland, the temporo-mandibular joint and soft tissue near the skull base. Most patients are elderly, latent or manifest diabetics. The causative organism was always proved to be Pseudomonas aeruginosa. The disease is called "malignant" because of its high mortality rate. Decreasing this mortality is possible - as demonstrated in 6 patients - via early diagnosis, sufficient surgery, as well as local and systemic antibiotics.

Adult↗
PubMed2002

Comparative efficacy of two anti-bacterial/anti-inflammatory formulations (Auricularum otic powder and Dex-Otic drops) in the medical treatment of otitis externa.

BACKGROUND: Otitis externa (OE) is a common disorder which can cause severe pain and discomfort with discharge and hearing loss. The majority of topical preparations for OE treatment contain a combination of steroids and antibiotics and are administered as ear drops. Otic powder preparations are less common. We found no studies which compared the efficacy of the two dosage forms. OBJECTIVE: The purpose of the study was to compare the healing process of the external ear canal when treated locally either with otic powder (Auricularum), a preparation containing antibiotic, steroidal and antimycotic components, or with otic drops (Dex-Otic), a commercial ear drop preparation containing antibiotic and steroidal components. METHODS: The study was designed as an open, randomised, comparative clinical trial. Ambulatory patients suffering from OE were examined by an ear specialist and randomly divided into an otic powder (Auricularum) treatment group and an ear drop (Dex-Otic) treatment group. Each treatment group was treated in accordance with the daily doses recommended by the manufacturers. Patients were treated for a period of 14 days and examined on days 0, 3, 7, 10 and 14. Clinical signs and symptoms recorded were pain, erythema, swelling and discharge. RESULTS: A total of 67 patients entered the study. The probability of healing within 7 days was 74% in the otic powder group as opposed to 40% in the ear drops group (log rank test, p = 0.0013). The probability of total pain relief after 3 days of treatment was 60% in the otic powder group compared to 53% in the ear drops group (log rank test, p = 0.0001). CONCLUSION: We conclude that treatment with an otic powder (Auricularum) may promote earlier healing and pain relief than does treatment with otic drops (Dex-Otic).

Administration, Topical↗
PubMed2006

Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.

INTRODUCTION: Otitis externa (OE) is an infection of the external auditory canal affecting children and adults and is associated with symptoms of local pain and tenderness. Twice-daily topical treatment with ofloxacin otic solution (0.3% [Floxin otic solution]) for 10 days has been reported to be as effective and well tolerated as neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension (Cortisporin otic suspension) administered four times daily for 10 days. OBJECTIVE: This study compared the efficacy, safety, and ear-pain resolution of once-daily ofloxacin otic solution (0.3%) versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension administered four times daily, in children with OE. RESEARCH DESIGN, PATIENTS, AND METHODS: This multicenter, randomized, parallel-group, evaluator-blinded study was conducted at 34 centers in 278 pediatric OE patients aged 6 months to 12 years. Patients received five drops of ofloxacin otic solution (0.3%) in the affected ears once daily or three drops of neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times daily, for 7-10 days. Patient evaluations were performed at pretherapy (day 1), end of therapy (days 7-9), and test of cure (7-10 days post-treatment) visits. Data for 208 patients were clinically evaluable and those for 90 patients were microbiologically evaluable. Scores were obtained for patient assessments of pain severity. MAIN OUTCOME MEASURES: The overall clinical response was cure in the clinically evaluable patients, demonstrated by resolution of OE signs and symptoms at the test of cure visit. The overall clinical-microbiological response was cure in the microbiologically evaluable patients demonstrated by both clinical cure and microbiological eradication. RESULTS: For the clinically evaluable patients, equivalent cure rates were obtained between the once-daily ofloxacin-treated and four-times-daily neomycin sulfate/polymyxin B sulfate/hydrocortisone-treated patients (93.8% and 94.7%, respectively). For the clinically and microbiologically evaluable patients, the overall cure rates were 96.4% versus 97.1% for the ofloxacin-treated and neomycin sulfate/polymyxin B sulfate/hydrocortisone-treated patients, respectively. The eradication rates for the prevalent pathogen, Pseudomonas aeruginosa, were 98% versus 100% for ofloxacin-treated and neomycin sulfate/polymyxin B sulfate/hydrocortisone-treated patients, respectively. Decreases in pain severity were similar in both treatment groups. Statistical analyses were limited by the small numbers of patients in each treatment group. CONCLUSION: In the treatment of OE in children, once-daily ofloxacin otic solution was as effective and safe as neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension given four times daily. The two treatments provide rapid and comparable pain relief; however, ofloxacin otic solution does not have the risk of ototoxicity associated with neomycin and provides effective pain relief without adjunctive steroids.

Administration, Topical↗